Genentech shares power ahead post listing

  • 23 Jul 1999
Investors are showing renewed interest in biotech stocks as the sector matures and profits increase. JP Morgan this week completed the IPO for one of the world's largest biotech companies, Genentech, raising $1.7bn. Swiss pharmaceuticals company Roche Holdings decided to float its Californian biotech subsidiary, having increased its ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 333,388.45 1292 8.11%
2 JPMorgan 324,697.38 1403 7.90%
3 Bank of America Merrill Lynch 298,038.11 1018 7.25%
4 Barclays 251,544.12 934 6.12%
5 Goldman Sachs 220,211.32 736 5.36%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 46,873.11 184 6.94%
2 JPMorgan 44,544.17 93 6.60%
3 UniCredit 36,560.82 157 5.42%
4 Credit Agricole CIB 33,820.44 161 5.01%
5 SG Corporate & Investment Banking 33,798.79 128 5.01%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 13,792.73 61 8.93%
2 Goldman Sachs 13,469.15 66 8.72%
3 Citi 9,908.67 56 6.42%
4 Morgan Stanley 8,471.86 53 5.49%
5 UBS 8,248.12 34 5.34%